Back to Search
Start Over
The approval of sintilimab for classical Hodgkin's lymphoma: views and perspectives of anti-PD-1/PD-L1 antibodies in China
- Source :
- Antibody Therapeutics
- Publication Year :
- 2019
- Publisher :
- Oxford University Press (OUP), 2019.
- Subjects :
- AcademicSubjects/SCI01030
biology
business.industry
Immune checkpoint inhibitors
Immunology
Anti pd 1
Sintilimab
Classical Hodgkin's Lymphoma
checkpoint inhibitor
PD-1 antibody
classic Hodgkin's lymphoma
PD-L1
biology.protein
Cancer research
Immunology and Allergy
Medicine
AcademicSubjects/SCI00100
Antibody
business
News and Views
Subjects
Details
- ISSN :
- 25164236
- Volume :
- 2
- Database :
- OpenAIRE
- Journal :
- Antibody Therapeutics
- Accession number :
- edsair.doi.dedup.....cb665454ccb0efccac8365860270319a
- Full Text :
- https://doi.org/10.1093/abt/tbz005